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Abstract
Miscarriage and pre-eclampsia are the most common disorders of human pregnancy. Both are
placental-related and exceptional in other mammalian species. Ultrasound imaging has enabled
events during early pregnancy to be visualized in vivo for the first time. As a result, a new
understanding of the early materno–fetal relationship has emerged and, with it, new insight into
the pathogenesis of these disorders. Unifying the two is the concept of placental oxidative stress,
with associated necrosis and apoptosis of the trophoblastic epithelium of the placental villous tree.
In normal pregnancies, the earliest stages of development take place in a low oxygen (O2)
environment. This physiological hypoxia of the early gestational sac protects the developing fetus
against the deleterious and teratogenic effects of O2 free radicals (OFRs). In miscarriage,
development of the placento–decidual interface is severely impaired leading to early and
widespread onset of maternal blood flow and major oxidative degeneration. This mechanism is
common to all miscarriages, with the time at which it occurs in the first trimester depending on the
aetiology. In contrast, in pre-eclampsia the trophoblastic invasion is sufficient to allow early
pregnancy phases of placentation but too shallow for complete transformation of the arterial
utero–placental circulation, predisposing to a repetitive ischaemia–reperfusion (I/R) phenomenon.
We suggest that pre-eclampsia is a three-stage disorder with the primary pathology being an
excessive or atypical maternal immune response. This would impair the placentation process
leading to chronic oxidative stress in the placenta and finally to diffuse maternal endothelial cell
dysfunction.
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Introduction
Placental-related disorders of pregnancy are almost unique to the human species. These
disorders, which affect around a third of human pregnancies, primarily include miscarriage
and pre-eclampsia. In other mammalian species, the incidence of both disorders is extremely
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low. Although epidemiological data on animals living in the wild, such as monkeys, are
limited, laboratory rodents are known to have post-implantation pregnancy loss rates of less
than 10% (Wilmut et al., 1986), and spontaneous pre-eclampsia has been exceptionally
described only in ‘patas’ monkeys (Palmer et al., 1979) and guinea pigs (Seidl et al., 1979).
In humans, both disorders have been known to medical science since ancient times with
clear descriptions recorded in ancient Egypt and Greece (Kuller and Katz, 1994; Pukerson
and Vekerdy, 1999). Recent changes in human lifestyle, such as delayed childbirth and
hypercaloric diets, may have increased the global incidence of placental-related disorders
over the last decades (Dietl, 2005). However, the fact that populations of hunter-gatherers
still in existence today are affected by these pregnancy complications (Roy, 2003) suggests
that they are not a direct consequence of modern human lifestyle but are more likely because
of an evolutionary step in human reproduction and development.
There is mounting evidence that oxidative stress or an imbalance in the oxidant/antioxidant
activity in utero–placental tissues plays a pivotal role in the development of placental-related
diseases. We have reviewed the experimental and clinical data and the mechanisms involved
in the alterations of oxygen (O2) homeostasis and evaluated the consequences for human
pregnancy.
Environmental O2 and mammalian evolution
Evolution for mammals living on dry land has been closely linked to adaptation to changes
in O2 concentration in the environment (Burton et al., 2003). Life on earth evolved under
anaerobic conditions, with metabolic pathways centred on nitrogen, sulphur and carbon. O2
was initially released as a by-product of photosynthesis following the emergence of blue-
green algae, and as atmospheric concentrations increased, it became possible to support
more complex, multicellular life forms, including placental mammals (Falkowski et al.,
2005). O2 enables more efficient energy transformation from dietary proteins, carbohydrates
and fats to ATP. ATP molecules provide the chemical energy required to conduct the
biochemical reactions essential to cellular life including protein biosynthesis, active
transport of molecules across cellular membranes and muscular contraction (Burton et al.,
2003). Most of the O2 used during the oxidation of dietary organic molecules is converted
into water via the combined action of the enzymes of the respiratory chain. Around 1–2% of
the O2 consumed escapes this process and is diverted into highly reactive O2 free radicals
(OFRs) and other reactive O2 species (ROS) at a rate dependent on the prevailing O2 tension
(Halliwell and Gutteridge, 1999). When the production of OFRs exceeds the natural cellular
protection, indiscriminate damage can occur to proteins, lipids and DNA.
The placenta in mammals is the essential interface between the maternal circulation carrying
O2-rich blood and nutrients and the fetal circulation. In the past, it has been assumed that the
principal function of the organ is to supply the fetus with as much O2 as possible, and to a
large extent that is the case in the second half of pregnancy when fetal weight gain is
greatest. Our recent combined in vivo and in vitro investigations have resulted in a new
understanding of the materno–fetal relationship during the first trimester of pregnancy and
led to the hypothesis that the placenta limits, rather than facilitates, O2 supply to the fetus
during the period of organogenesis (Jauniaux et al., 2003a). The earliest stages of
development therefore take place in a low O2 environment, reflecting to some extent the
evolutionary path (Figure 1). In most species, organogenesis is complete and development is
very advanced before placental attachment. However, in the human placenta, development is
precocious, and the conceptus is fully embedded in the uterine wall before the primitive
streak has formed. Consequently, other strategies need to be employed to restrict exposure
of the fetus to O2, and as a result, the human placenta is exposed to major changes in O2
concentration from conception to delivery (Jauniaux et al., 2000, 2001; Burton et al., 2003).
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In normal pregnancies, this is a very well controlled phenomenon that has to provide a
delicate balance between the metabolic needs of the fetus and its placenta and the potential
danger of OFRs. Embryonic and placental cells are sensitive to oxidative stress because of
their extensive cell divisions and the concomitant exposure of their DNA (Burton et al.,
2003). The placental syncytiotrophoblast is particularly sensitive, partly because it is the
outermost tissue of the conceptus and so exposed to the highest concentrations of O2 coming
from the mother, and partly because it contains surprisingly low concentrations of the
principal antioxidant enzymes, particularly in early pregnancy (Watson et al., 1998). Thus, it
is well established that maternal metabolic disorders such as diabetes, which are associated
with an increased generation of OFRs, are known to be associated with a higher incidence of
miscarriages, vasculopathy and fetal structural defects (Burton et al., 2003; Jawerbaum and
Gonzales, 2005), indicating that the mammalian conceptus can be irreversibly damaged by
oxidative stress.
Human early placentation
Human implantation is almost unique amongst mammals in that it is highly invasive and the
conceptus embeds itself completely within the maternal uterine endometrium and superficial
myometrium. The chorionic villi, the basic structures of the early placenta, form during the
4th and 5th weeks post-menstruation (Boyd and Hamilton, 1970) and surround the entire
gestational sac until the 8th to 9th week of gestation. Between the 3rd and 4th month, the
villi at the implantation site become elaborately branched and form the definitive placenta,
whereas the villi on the opposite pole degenerate to form the placental membranes (Figure
2). Towards the end of pregnancy, the villi present a surface area of 12–14 m2, providing an
extensive and intimate interface for materno–fetal exchange (Boyd and Hamilton, 1970).
The trophoblast lineage gives rise to three main cell types in the human placenta: (i) the
syncytiotrophoblast which forms the epithelial covering of the villous tree and is the main
endocrine component of the placenta, (ii) the villous cytotrophoblast cells which represent a
germinative population that proliferate throughout pregnancy and fuse to generate the
syncytiotrophoblast (iii) and the extravillous trophoblast cells which are non-proliferative
and invade the maternal endometrium (Kaufmann and Burton, 1994). These extravillous
trophoblasts can be first found both within and around the spiral arteries in the central area
of the placenta. They gradually extend laterally, reaching the periphery of the placenta
around mid-gestation (Figure 2). Depth-wise changes normally extend as far as the inner
third of the uterine myometrium within the central region of the placental bed, but the extent
of invasion is progressively shallower towards the periphery (Pijnenborg et al., 1980).
Human placentation is also characterized by a remodelling of the spiral arteries during
which the vessels lose their elastic lamina and smooth muscle, and consequently their
responsiveness to circulating vasoactive compounds. In normal pregnancies, the
transformation of spiral arteries into utero–placental arteries is completed around mid-
gestation. The main aim of these vascular changes is to optimize the distribution of maternal
blood into a low-resistance uterine vascular network and ultimately inside the placental
intervillous chamber. At term, the utero–placental circulation carries approximately 600 ml
of maternal blood per minute (Ramsey and Donner, 1980).
Recent anatomic and in vivo studies have shown that human placentation is in fact not truly
haemochorial in early pregnancy. From the time of implantation, the extravillous trophoblast
not only invades the uterine tissues but also forms a continuous shell at the level of the
decidua (Figure 2). The cells of this shell anchor the placenta to the maternal tissue but also
form plugs in the tips of the utero–placental arteries (Hustin and Schaaps, 1987; Burton et
al., 1999). The shell and the plugs act like a labyrinthine interface that filters maternal blood,
permitting a slow seepage of plasma, but no true blood flow, into the intervillous space. This
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is supplemented by secretions from the uterine glands, which are discharged into the
intervillous space until at least 10 weeks (Burton et al., 2002). During that period, the
placental villi display only a few capillaries and fetal erythrocytes are nucleated (Boyd and
Hamilton, 1970), suggesting that the fetal blood is extremely viscous, and consequently the
feto–placental blood flow is limited. Furthermore, during the first trimester, the villous
membrane is twice the thickness it will be in the second, and the early placenta and fetus are
separated by the exocoelomic cavity, which occupies most of the space inside the gestational
sac (Figure 2) (Jauniaux and Gulbis, 2000).
At the end of the first trimester, the trophoblastic plugs are progressively dislocated,
allowing maternal blood to flow progressively more freely and continuously within the
intervillous space. During the transitional phase of 10–14 weeks gestation, two-thirds of the
primitive placenta disappears, the exocoelomic cavity is obliterated by the growth of the
amniotic sac and maternal blood flows progressively throughout the entire placenta
(Jauniaux et al., 2003a). These events bring the maternal blood closer to the fetal tissues,
facilitating nutrient and gaseous exchange between the maternal and fetal circulations.
Human placentation and oxidative stress
The comparison of morphological features with physiological data reveals that the
architecture of the human first trimester gestational sac is designed to limit fetal exposure to
O2 to that which is strictly necessary for its development (Jauniaux et al., 2003a). In vivo
data have demonstrated that values for the intraplacental partial pressure of O2 (PO2) are
two to three times lower at 8–10 weeks than after 12 weeks (Jauniaux et al., 2000, 2001). As
pregnancy advances between 7 and 16 weeks, there is a progressive, but independent,
increase in decidual PO2, which most probably reflects the increase in maternal blood flow
volume within the uterine circulation during the first half of pregnancy. At 13–16 weeks, the
PO2 in the fetal blood is still only 24 mmHg, whereas during the second half of pregnancy,
umbilical venous values ranges between 35 and 55 mmHg. These are relatively low
compared with the maternal circulation, suggesting a significant maternal to fetal O2
gradient throughout pregnancy. The gradual rise in intraplacental PO2 change observed
between 8 and 14 weeks of gestation is accompanied by almost parallel increases in mRNA
concentrations and the activity of the major antioxidant enzymes in the villous tissue
(Jauniaux et al., 2000). The first trimester uterine O2 gradient exerts a regulatory effect on
placental tissue development and function. In particular it influences cytotrophoblast
proliferation and differentiation along the invasive pathway (Genbacev et al., 1997) and
villous vasculogenesis (Charnock-Jones and Burton, 2000).
The physiological hypoxia of the first trimester gestational sac may protect the developing
fetus against the deleterious and teratogenic effects of OFRs. Recent evidence also indicates
that the hypoxia is necessary to maintain stem cells in a fully pluripotent state (Ezashi et al.,
2005), for at physiological levels free radicals regulate a wide variety of cell functions, in
particular transcription factors (Burton et al., 2003). Excessive production of OFRs results in
oxidative stress, and there are two examples when this occurs physiologically during human
pregnancy.
Firstly, at the end of the first trimester, a burst of oxidative stress is evidenced in the
periphery of the early placenta (Jauniaux et al., 2000). The underlying utero–placental
circulation in this area is never plugged by the trophoblastic shell allowing limited maternal
blood flow to enter the placenta from 8 to 9 weeks of gestation (Figures 2 and 3). This leads
to higher local O2 concentrations at a stage of pregnancy when the trophoblast possesses low
concentrations and activities of the main antioxidant enzymes superoxide dismutase,
catalase and glutathione peroxidase. Focal trophoblastic oxidative damage and progressive
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villous degeneration trigger the formation of the fetal membranes (Jauniaux et al., 2003b),
which is an essential developmental step enabling vaginal delivery. The oxidative stress and
rise in oxygenation may also stimulate the synthesis of various trophoblastic proteins, such
as hCG and estrogens. Maternal serum concentrations of hCG peak towards the end of the
first trimester, and oxidising conditions promote assembly of the subunits in vitro (Xing et
al., 2001). Concentrations of hCG are further increased in cases of trisomy 21, where there is
evidence of trophoblastic oxidative stress through an imbalance in expression of the
antioxidant enzymes (Pidoux et al., 2004). Recently, it has been demonstrated that the
enzyme P-450 cytochrome aromatase (CYP19) which is involved in the synthesis of
estrogens is transcriptionally regulated by O2 (Mendelson et al., 2005), and this may account
for the significant increase in production at the start of the second trimester.
The second example involves an ischaemia–reperfusion (I/R) phenomenon. Angiographic
studies of the uterine vasculature of the rhesus monkey have demonstrated that during
normal pregnancy, flow from spiral arteries into the intervillous space is often intermittent,
arising from spontaneous vasoconstriction (Martin et al., 1964). Placental inflow may also
be compromised by external compression of the arteries during uterine contractions in both
the rhesus and human and even by postural changes (Ramsey and Donner, 1980). Some
degree of I/R stimulus may therefore be a feature of normal human pregnancy, especially
towards term when the fetus and placenta are extracting large quantities of O2 from the
intervillous space (Hung et al., 2001). This chronic stimulus could lead to up-regulation of
the anti-OFR defence in the placenta, thus reducing oxidant stress. As in early pregnancy,
this well-controlled oxidative stress may play a role in continuous placental remodelling and
essential placental functions such as transport and hormonal synthesis. Within this context,
miscarriages and pre-eclampsia could be a temporary maladaptation to a changing O2
environment.
Miscarriages and oxidative stress
Early anatomical and histopathological studies have almost exclusively focused on abnormal
villous development in early pregnancy failure (Boue et al., 1976). There is now clear
evidence that miscarriages are a placentation disorder and that the villous changes described
previously are the consequence, rather than the cause (Jauniaux and Burton, 2005). In about
two-thirds of early pregnancy failures, there is anatomical evidence of defective placentation
which is mainly characterized by a thinner and fragmented trophoblast shell, reduced
cytotrophoblast invasion of the endometrium and incomplete plugging of the lumen at the
tips of the spiral arteries (Hustin et al., 1990; Jauniaux et al., 1994). This is associated with
the absence of physiological changes in most spiral arteries and leads to a premature onset of
the maternal circulation throughout the entire placenta.
Independent of the cause of the miscarriage, the excessive entry of maternal blood into the
intervillous space has two effects: (i) a direct mechanical effect on the villous tissue which
becomes progressively enmeshed inside large intervillous blood thrombi (ii) and a
widespread and indirect O2-mediated trophoblastic damage and increased apoptosis
(Kokawa et al., 1998; Hempstock et al., 2003; Jauniaux et al., 2003b). Concentrations of
lipid peroxides have also been shown to increase in the villous and decidual tissues of
women undergoing early pregnancy loss (Nicol et al., 2000; Sugino et al., 2000). Overall,
the consequences are placental degeneration with complete loss of syncytiotrophoblast
function and detachment of the placenta from the uterine wall. This mechanism is common
to all miscarriages, with the time at which it occurs in the first trimester depending on the
aetiology.
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Any factor causing abnormally high or rapidly fluctuating concentrations of O2 will have a
harmful and rapid effect on the early villous tissue. We have proposed separation of the
aetiologies of early pregnancy failure into primary and secondary causes of O2 stress
(Hempstock et al., 2003). Primary causes can be clearly defined and include mainly
chromosomal abnormalities which are found in at least 50% of miscarriages and are often
associated with abnormal trophoblastic invasion of the uterine decidua (Hustin et al., 1990;
Jauniaux and Burton, 2005). There is also increasing evidence showing an association
between miscarriages and an anomaly of one of the enzymes involved in the metabolism of
OFRs (Nicol et al., 2000; Sugino et al., 2000; Tempfer et al., 2001; Sata et al., 2003). These
data support the concept that an early pregnancy failure could arise from a primary defect of
placentation subsequent to a genetic anomaly of the enzymes or co-factors involved in the
metabolism of O2.
Secondary causes are more complex and often multifactorial. For example, the role of
maternal leukocytes and other immune factors such as cytokines in the trophoblast–decidual
interaction remains unclear. There is evidence that the circulating cytokine levels and the
cytokine profile in the decidua are different in women who experience recurrent
miscarriages (Jenkins et al., 2000; Makhseed et al., 2000; von Wolff et al., 2000; Baxter et
al., 2001), but the exact interaction of each of these cytokines with the invading trophoblast
is not well defined. Some diseases such as maternal diabetes can generate OFRs in larger
quantities than the early placental limited antioxidant defences can cope with (Burton et al.,
2003), leading to DNA damage and oxidation of proteins and lipids, thus resulting in
secondary trophoblast dysfunction. Although is has been shown that women with naturally
higher levels of antioxidant enzymes are less likely to miscarry (Baxter et al., 2001), the
impact of peri-conceptional antioxidant supplementation on early pregnancy failure rates in
the general population remains to be investigated. Theoretically, major fetal abnormalities
leading to fetal demise within the first 2 months of pregnancy could also lead to a secondary
placental dysfunction as the placental development becomes increasingly dependent on fetal
synthesis towards the end of the first trimester (Shurtz-Swirski et al., 1991). This may be
modulated by tumour necrosis factor (TNF)-α, a multifunctional cytokine which has been
identified in the maternal reproductive tract, the placenta and fetal tissues (Toder et al.,
2003).
Pre-eclampsia and oxidative stress
Pre-eclampsia stems from a similar, though lesser, defect in early trophoblast invasion, for
although invasion is sufficient to anchor the conceptus, it is insufficient to fully convert the
spiral arteries into low-resistance channels (Robertson et al., 1985; Khong et al., 1986;
Meekins et al., 1994). Incomplete conversion of the spiral arteries results in retention of
smooth muscle cells within their walls (Figure 3), and so some vasoreactivity persists in 30–
50% of the placental vascular bed. This may lead not only to diminished perfusion of the
intervillous space but more importantly to intermittent perfusion. Because the placenta and
fetus continually extract O2, it is expected that transient hypoxia will result (Hung et al.,
2001) and that consequently the placenta suffers a chronic low-grade I/R type injury.
Increased O2 stress in the placenta of women with pre-eclampsia is well documented (Hubel
et al., 1989; Wang et al., 1991; Uotila et al., 1993; Lorentzen et al., 1994; Walsh, 1994;
Walsh and Wang, 1995; Myatt et al., 1996; Poranen et al., 1996; Wang and Walsh, 1998;
Staff et al., 1999; Many et al., 2000; Wang and Walsh, 2001; Zusterzeel et al., 2001;
Vanderlie et al., 2005). The disturbance in the oxidant–antioxidant balance renders the tissue
more vulnerable to OFR injury. OFRs lead to the formation of lipid peroxides which alter
cell membranes by increasing incorporation of cholesterol and oxidized free fatty acids
(FFAs) and low-density lipoproteins (LDLs) (Hubel et al., 1989). Lipid peroxides are
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directly involved in mediating maternal endothelial dysfunction by increasing the production
of thromboxane A2 and the expression of cell adhesion molecules in the utero–placental
vasculature and also in the maternal peripheral vasculature (Uotila et al., 1993; Walsh and
Wang, 1995; Myatt et al., 1996; Poranen et al., 1996; Wang and Walsh, 2001). Lipid
peroxides are increased in the maternal circulation above non-pregnant levels even in
normal pregnancy, indicating a certain degree of physiological oxidative stress (Walsh,
1994). FFAs are particularly susceptible to oxidation and are increased in pre-eclampsia,
15–20 weeks before the onset of the clinical disease (Lorentzen et al., 1994), and may
contribute to the susceptibility to maternal oxidant stress.
In pre-eclampsia, antioxidant nutrients are presumed to be utilized to a greater extent to
counteract OFRs, and this may provide an explanation for the repeated demonstration of
reduced concentrations of ascorbic acid in the maternal circulation (Mikhail et al., 1994).
This rapid decrease in antioxidant capacity would propagate lipid peroxidation leading to the
biological cascade of leukocyte activation, platelet adhesion and aggregation and the
consequent release of vasoconstriction agents. Although it is clear that maternal and
placental antioxidant defences are reduced in pre-eclampsia, it is not known whether this is a
primary or secondary event to excessive depletion through the increased generation of
OFRs. Changes in some circulating markers of O2 stress precede the development of the
clinical symptoms (Wang et al., 1991; Lorentzen et al., 1994; Mikhail et al., 1994; Chappell
et al., 2002a; Scholl et al., 2005), suggesting a primary phenomenon of chronic oxidative
stress. By contrast to miscarriage where there is rapid and generalized placental tissue
degeneration, in pre-eclampsia the placental damage is progressive and can be compensated
for sometime depending on the severity of initial placental defect and the intrinsic placental
antioxidant capacity. This is supported by a clinical trial in women at risk of pre-eclampsia
which has shown that antioxidant vitamin C and E supplementation during the second
trimester of pregnancy improves biochemical incidences of oxidative stress and decreases
the occurrence of the clinical disease in high-risk women (Chappell et al., 1999, 2002b).
It has been known for more than 100 years that during pregnancy trophoblastic cells are
deported into the maternal venous circulation and that these may be detected peripherally;
indeed they have been detected in the lung (Schmorl, 1883). Although this is not exclusively
a human phenomenon, this so-called physiological desquamation of the villous
syncytiotrophoblast is found in all human pregnancies. Normal placentation is associated
with a certain degree of trophoblastic necrosis and apoptosis with shedding of placental
debris in the maternal circulation. Apoptotic or necrotic cellular debris could constitute the
basis of the inflammatory stimulus in all pregnancies and is found to increase with
advancing gestation (Redman and Sargent, 2000). This model could explain some features
of pre-eclampsia including its development in multiple pregnancies or in small oxidatively
stressed placentae (Redman et al., 1999).
There is little doubt that the pathophysiology of pre-eclampsia in humans involves an
imbalance in the maternal immune response to the placenta, and one prominent classical
hypothesis is that pre-eclampsia is caused by immune maladaptation. First-time mothers are
at increased risk of pre-eclampsia, and the risk decreases with the length of time she is
exposed to the semen of the father of her baby (Einarsson et al., 2003). In black populations,
the high incidence of pre-eclampsia could be because of subtle mutations in human
leukocyte antigen (HLA)-G, one of the major histocompatibility complex (MHC) genes (van
der Ken and Ober, 1994). This could lead to an increased cytolytic activation of decidual
and blood leukocytes, which are generally inhibited by MHC molecules expressed on the
cell surface (Shorter et al., 1993). Extravillous trophoblast cells express HLA-G, unlike
syncytiotrophoblast, and would therefore be more vulnerable to mutations. Thus, defective
HLA-G function could contribute to the low trophoblast invasion and vascular abnormalities
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observed in pre-eclamptic placentas (Le Bouteiller et al., 2003). HLA-G genotypes and
expression seem to have a significant influence on the development of pre-eclampsia
(Hylenius et al., 2004), and it has recently been shown that HLA-G levels in plasma from
women who subsequently develop pre-eclampsia are lower than in control patients, as early
as the first trimester (Yie et al., 2005). Similarly, combinations of killer immunoglobulin
receptors on maternal natural killer cells and fetal HLA-C genes influence the risk of pre-
eclampsia (Hiby et al., 2004).
There is also mounting evidence indicating that chronic maternal infection including
cytomegalovirus-related villitis and periodontal disease is associated with a higher risk of
pre-eclampsia (Loez et al., 2002; Von Dadelszen and Magee, 2002; Boggess et al., 2003;
Hasegawa et al., 2003; Moore et al., 2004). Some authors have also found an association
between these chronic infections and late miscarriage, fetal growth restriction and pre-term
labour which could all be linked to chronic leukocyte activation and cytokine production
(Hasegawa et al., 2003). The placental bed of women with pre-eclampsia is infiltrated with
activated macrophages which release molecules that are capable of reducing trophoblastic
invasiveness and even initiating apoptosis (King et al., 1991; Trundley and Moffett, 2004).
Activated decidual leukocytes may also be a major source of OFRs, and they may produce
cytokines which increase the inflammatory reaction (Stark, 1993).
The above findings suggest that pre-eclampsia is a three-stage rather than a two-stage
disorder (Roberts and Hubel, 1999), with the primary pathology being an excessive or
atypical maternal immune response. This would impair the placentation process leading to
chromic oxidative stress in the placenta and finally to diffuse maternal endothelial cell
dysfunction (Hung et al., 2004). The nature of the inflammatory response and oxidative
stress seen in pre-eclampsia are not intrinsically different from those seen in normal
pregnancies. The difference is one of degree, which strongly suggests that pre-eclampsia is
at the extreme end of a continuum of changes seen in every pregnancy.
Human evolution and placental-related disorders
Whatever the factors involved in controlling the materno–placental interaction, the aim is to
enable implantation, placentation and the subsequent progressive transformation of the
maternal vasoreactive spiral arteries into flaccid, distended utero–placental arteries needed
to supply the developing fetus and its placenta with an increasing amount of maternal blood
in later pregnancy.
The form of placentation varies widely across mammalian species, but as yet no satisfactory
explanation of the evolutionary driving forces has been provided. In most species, there is
no invasion of the maternal endometrium, and the conceptus remains within the uterine
lumen throughout gestation. The extraembryonic membranes are simply apposed to the
uterine epithelium, establishing a relationship classified as epitheliochorial. In others,
particularly the carnivores, there is limited erosion of the maternal tissues so that the
trophoblast is apposed to the endothelium of the maternal vessels, forming an
endotheliochorial placenta. In the past, it has been assumed that the increasing depth of
invasion was evidence of evolutionary progression, with the haemochorial situation
representing the most advanced state. By providing trophoblast with direct access to the
maternal blood, it was thought that the haemochorial situation permitted more efficient
transfer of nutrients, including O2, which allowed for greater development of the brain
(Martin, 2003). However, dolphins which have epitheliochorial placentae produce large-
brained fetuses second only in size to human fetuses (Martin, 2003). More recently, cladistic
analyses have suggested that in fact the endotheliochorial relationship is the most primitive
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form and that the epitheliochorial and haemochorial relationships are parallel advancements
(Vogel, 2005).
Despite the potential advantages for materno–fetal transfer it provides, the haemochorial
relationship undoubtedly has a number of potential drawbacks. Firstly, there is a risk that the
fetal capillaries within the placental villi may be compressed by the higher pressure inherent
in the maternal circulation (Karimu and Burton, 1994). It is therefore essential that the
pressure in the intervillous space is kept lower than fetal venous pressure, requiring a
pressure drop from mean maternal arterial pressure to approximately 10 mmHg. Trophoblast
invasion and conversion of the uterine arteries in haemochorial placentation is more likely to
be important in this respect and in ensuring constancy of flow, rather than simply increasing
uterine artery blood flow. The latter occurs in all species irrespective of trophoblast invasion
and is an endocrine-mediated effect. As we have seen, however, the phenomenon of
trophoblast invasion brings with it another set of immunological problems, and these have to
be balanced evolutionarily against the benefits of the haemochorial relationship for nutrient
transfer. The precise details of the latter remain obscure at present.
Secondly, in the haemochorial state, once maternal blood has been released into the
placenta, there is little control over the direction or rate of flow, save for the uterine aterio–
venous pressure differential. In contrast, retaining the maternal blood within a capillary
network in the epitheliochorial and endotheliochorial situations allows maternal and fetal
perfusion of the placenta to be matched more closely, and hence major fluctuations in
oxygenation are likely to be less common. Finally, the haemochorial situation allows the
trophoblast uniquely intimate and extensive access to the maternal circulation. Inflammatory
cytokines, soluble receptors, fetal DNA and trophoblastic debris can all be released with
ease directly into the maternal blood and hence disseminated widely throughout the mother's
body. This is in stark contrast to the situation in, for example, an epitheliochorial placenta
where trophoblast microparticles would have to cross the uterine epithelium, its basement
membrane, any intervening stromal tissue and finally the capillary endothelium in order to
gain similar access.
Miscarriages are the most common human pregnancy disorder with 50% of all conceptions
lost before or around implantation and another 20% lost between implantation and
completion of the first trimester (Edmonds et al., 1982; Norwitz et al., 2001). The difference
in miscarriage rates between humans and other mammals including primates is linked to a
difference in chromosomal abnormalities which occur at a rate of more than 50% in humans
compared with less than 5% in rats, rabbits and hamsters (Hassold, 1986). The high rate of
chromosomal abnormalities in humans could be because of the longer reproductive spans of
humans which would lead to an accumulation of chromosomal errors not observed in short-
lived mammalian species (Hassold, 1986). Indeed, the incidence of chromosomal
abnormalities in the human conceptus increases with maternal and paternal age. Other
known causes of miscarriages such as infections have been described in both humans and
other mammals but account for only a small percentage of early pregnancy losses. Modern
lifestyle and in particular delayed childbirth, maternal smoking and hypercaloric diets
leading to diabetes have most certainly increased the incidence of miscarriage in the general
population worldwide. The high incidence of miscarriages in the human could also reflect
the separation of coitus from ovulation, with the risk of post-ovulatory aged oocytes and
post-ejaculatory aged sperm throwing up genetic abnormalities. Overall, all causes of
miscarriages lead to major trophoblastic dysfunction with major disturbances of the early
phases of the placentation process.
Threatened miscarriages are to be considered separately from other forms of miscarriages as
they result from a focal bleed in the periphery of the developing placenta. This bleed occurs
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at the time of the formation of the membranes and can lead to a complete miscarriage if the
hematoma extends into the definitive placenta (Johns et al., 2003). Very early (in the first 8
weeks) vaginal bleeding is not associated with subsequent pregnancy complications,
whereas the formation of an intrauterine hematoma at 13–14 weeks increases the risk of pre-
eclampsia (Harville et al., 2003). The presence of a haematoma may also be associated with
a chronic inflammatory reaction in the decidua resulting in persistent myometrial activity
and expulsion of the pregnancy or progressive cellular dysfunction and/or damage to cellular
layers of the membranes leading to pre-term rupture and delivery (Silver et al., 2005).
Whatever the evolutionary benefits of haemochorial placentation, it appears to be a key
factor in the high rate of this very common complication of human gestation, affecting
between 10 and 15% of ongoing pregnancies.
Human physiological adjustments to pregnancy resemble those of our primate relatives but
differ in several key aspects; most notably, humans have earlier, deeper and more extensive
placentation. The human placenta is also larger relative to the uterine size (Martin, 2003). It
has been suggested that the human placenta is designed as a means for overcoming the
mechanical constraints and consequent reduction in cardiac output because of bipedal
posture (Rockwell et al., 2003). The genetic conflict hypothesis predicts that maternal blood
pressure is determined by the balance between fetal and placental paternally-inherited
factors increasing blood pressure and maternal factors decreasing blood pressure (Haig,
1993). The paternal contribution tends to favour invasiveness of the placenta and thus
increases feto–placental capture of maternal resources, whereas the maternal contribution
tends to favour a lesser degree of placental response and to promote fetal brain development
(Keverne et al., 1996). The placental response invasion may be a secondary strategy to
increase non-placental resistance when the utero–placental blood supply is inadequate, but if
so, it would appear to be a highly risky one.
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Figure 1.
Diagram showing the oxygen (O2) delivery system in the adult body (left) to ensure that
cells are not exposed to the full atmospheric concentration and excessive oxidative stress;
plugging of the maternal spiral arteries and the presence of the large exocoelomic cavity
(right), devoid of an O2 carrier, could serve as a similar protective mechanism for embryonic
tissues during the first trimester.
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Figure 2.
Diagram of a gestational sac at the end of the 2nd month showing the myometrium (M), the
decidua (D), the placenta (P), the exo-coelomic cavity (ECC), the amniotic cavity (AC) and
the secondary yolk sac (SYS).
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Figure 3.
Diagram of the utero–placental interface in the first trimester and later in pregnancy showing
the reduced cytotrophoblastic plugging and incomplete transformation of the spiral arteries
in pregnancies complicated by pre-eclampsia.
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